Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Conserved protein | 0.0696 | 1 | 0.5 |
Brugia malayi | hypothetical protein | 0.0286 | 0.3831 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.0692 | 0.0332 |
Echinococcus multilocularis | geminin | 0.0205 | 0.2615 | 0.233 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.0692 | 0.1805 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0372 | 0.0215 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0692 | 0.0539 |
Schistosoma mansoni | sphingosine kinase A B | 0.0696 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.3831 | 0.3831 |
Mycobacterium ulcerans | hypothetical protein | 0.0696 | 1 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0418 | 0.0261 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0418 | 0.0261 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0692 | 0.0539 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0692 | 0.0539 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.0692 | 0.0692 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0372 | 0.0215 |
Echinococcus granulosus | geminin | 0.0205 | 0.2615 | 0.233 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.0696 | 1 | 1 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.0696 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.0692 | 0.0692 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0692 | 0.0539 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2615 | 0.2495 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2615 | 0.2495 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.0692 | 0.1805 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0447 | 0.0447 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0418 | 0.109 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0447 | 0.0447 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0161 | 0.0161 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0447 | 0.1167 |
Brugia malayi | RNA binding protein | 0.0076 | 0.0692 | 0.1805 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0447 | 0.1167 |
Onchocerca volvulus | 0.0058 | 0.0418 | 0.5 | |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0372 | 0.0972 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0692 | 0.0539 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.3831 | 0.3592 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.0692 | 0.0692 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.0692 | 0.0332 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0161 | 0.042 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0372 | 0.0372 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.3831 | 0.3592 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0696 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0696 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0372 | 0.0215 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.3548 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.